University Of Nebraska Medical Center ( Site 0035) — Omaha, Nebraska

Public research footprint of University Of Nebraska Medical Center ( Site 0035), compiled from the ClinicalTrials.gov public registry.

1,575

Registered studies

494

Active

243

Recruiting now

850

Completed

186

Stopped or withdrawn

Most-studied conditions

Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma · Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma · EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Acute Myeloid Leukemia

Recently updated registry entries

NCT04739800 — Comparison of Standard of Care Treatment With a Triplet Combination of Targeted… (Active Not Recruiting)
NCT05987241 — Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of… (Recruiting)
NCT06997497 — A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University Of Nebraska Medical Center ( Site 0035)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.